Coca-Cola's fizzy situation with the ATO | ExxonMobil enters lithium | Pfizer's weight-loss drug - podcast episode cover

Coca-Cola's fizzy situation with the ATO | ExxonMobil enters lithium | Pfizer's weight-loss drug

Nov 14, 20236 min
--:--
--:--
Listen in podcast apps:

Episode description

The Coca-Cola Company is in a fizzy situation as it battles a $170 million in tax case with the Australian Tax Office.

ExxonMobil, one of the largest oil and gas companies in the world, has announced plans to become a “leading producer” of lithium for electric vehicles.

Pfizer is creating a new weight-loss drug to try and steal a chunk of the rapidly growing weight-loss drug market.

Build the financial wellbeing of your team with Flux at Work: https://bit.ly/fluxatwork

Download the free app (App Store): http://bit.ly/FluxAppStore

Download the free app (Google Play): http://bit.ly/FluxappGooglePlay

Daily newsletter: https://bit.ly/fluxnewsletter

Flux on Instagram: http://bit.ly/fluxinsta

Flux on TikTok: https://www.tiktok.com/@flux.finance

—-

The content in this podcast reflects the views and opinions of the hosts, and is intended for personal and not commercial use. We do not represent or endorse the accuracy or reliability of any opinion, statement or other information provided or distributed in these episodes.

See omnystudio.com/listener for privacy information.

Coca-Cola's fizzy situation with the ATO | ExxonMobil enters lithium | Pfizer's weight-loss drug | What the Flux podcast - Listen or read transcript on Metacast